Product Information
MESALAMINE DR 400 MG CAPSULE is a generic product labeled by Greenstone LLC, priced at $2.3504 per EA under NDC 59762011701. Its NADAC has been published 363 times since Jul 17, 2019.
Strength
400 mg/1
Manufacturer
Greenstone LLCNDC
59762011701
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204412On Market Since
5/10/2019
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 400 MG CAPSULE has been published 363 times since Jul 17, 2019, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3504 per EA |
|---|---|
| All-time high | $2.5848 (May 11, 2022) |
| All-time low | $1.5286 (Jul 17, 2024) |
| 52-week high | $2.4055 |
| 52-week low | $2.0896 |
| Median price | $2.1058 |
| Average price | $2.1049 |
| Largest weekly change | +29.8% (Aug 21, 2024) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the MESALAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MESALAMINE DR 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 400 MG CAPSULE, manufactured by Greenstone LLC, is $2.3504 per EA (NDC 59762011701), effective Jun 24, 2026.
How has the price of MESALAMINE DR 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 400 MG CAPSULE has declined 8.3%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 400 MG CAPSULE?
Since Jul 17, 2019, the NADAC for MESALAMINE DR 400 MG CAPSULE has ranged from a low of $1.5286 (Jul 17, 2024) to a high of $2.5848 (May 11, 2022), with a median of $2.1058 per EA.
Are there cheaper alternatives to MESALAMINE DR 400 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MESALAMINE DR 400 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures MESALAMINE DR 400 MG CAPSULE?
MESALAMINE DR 400 MG CAPSULE (NDC 59762011701) is labeled by Greenstone LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification